# A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects

> **NCT06462118** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 78 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Astegolimab

## Key facts

- **NCT ID:** NCT06462118
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-17
- **Primary completion:** 2024-10-22
- **Final completion:** 2024-10-22
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06462118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06462118, "A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06462118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*